Edwards Lifesciences Corp
Held by 3 superinvestors (EW).
Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.
Ownership · 13F consensus
Who's buying it
Institutional ownership aggregated across funds — consensus strength and this quarter's moves. Describes actions, not advice.
3 superinvestors hold it · $115.4M combined
Largest holder Andreas Halvorsen
Held by 3 superinvestors of Edwards Lifesciences Corp (EW); this quarter 1 opened, 1 added, 1 trimmed (as of 2026-03-31).
13F positions are self-reported and can lag up to 45 days. Informational only — not investment advice.
Superinvestors Holding This Security
- Value$87.9MWeight (prev→now)New · 0.2%
- Value$13.8MWeight (prev→now)0.0% → 0.1% ▲
- Value$13.7MWeight (prev→now)2.9% → 2.8% ▼
Ownership overview
Edwards Lifesciences Corp (EW) is held by 3 of the superinvestors tracked on Compounder, with a combined $115.4M in reported 13F value. The largest position belongs to Andreas Halvorsen, where it makes up 0.2% of the portfolio.
Other notable holders by value include Ray Dalio (0.1% of its book) and David Rolfe (2.8% of its book).
Over the latest quarter, 1 of the tracked filers opened a new position in EW, 1 added to existing ones, 1 trimmed, and 0 sold out entirely.
Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-03-31. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.
Holders over time
Superinvestors holding this security over the last 8 quarters: 3 → 3.
Early quarters may understate holder counts due to data backfill — read the slope with care.
Sources· SEC EDGAR 13F as of 2026-05-15
Stay Updated
Curated 13F moves and valuation insights, straight to your inbox.